GenMont Biotech Inc
GenMont Biotech Incorporation engages in the research and development, manufacture, and sale of various probiotic health products in Taiwan. It offers OEM and ODM services, including functional probiotic raw materials, capsules, powder, tablets, and liquid products. The company was founded in 2000 and is based in Tainan City, Taiwan.
GenMont Biotech Inc (3164) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: -0.003x
Based on the latest financial reports, GenMont Biotech Inc (3164) has a cash flow conversion efficiency ratio of -0.003x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$-4.77 Million) by net assets (NT$1.39 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
GenMont Biotech Inc - Cash Flow Conversion Efficiency Trend (2005–2024)
This chart illustrates how GenMont Biotech Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
GenMont Biotech Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of GenMont Biotech Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Kukbo Design Co. Ltd
KQ:066620
|
0.052x |
|
American Eagle Gold Corp
PINK:AMEGF
|
-0.154x |
|
Taiwan Alpha Electronic Co Ltd
TWO:6204
|
0.009x |
|
TechPrecision Corporation Common stock
NASDAQ:TPCS
|
-0.119x |
|
Ersan Alisveris Hizmetleri & Gida Sanayi Ticaret AS
IS:KIMMR
|
0.093x |
|
Tefron Ltd
PINK:TFRFF
|
-0.024x |
|
Awanbiru Technology Bhd
KLSE:5204
|
0.539x |
|
Oncopeptides AB
ST:ONCO
|
-23.926x |
Annual Cash Flow Conversion Efficiency for GenMont Biotech Inc (2005–2024)
The table below shows the annual cash flow conversion efficiency of GenMont Biotech Inc from 2005 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | NT$1.48 Billion | NT$123.95 Million | 0.084x | +250.84% |
| 2023-12-31 | NT$1.45 Billion | NT$34.60 Million | 0.024x | -74.09% |
| 2022-12-31 | NT$1.50 Billion | NT$137.95 Million | 0.092x | +25.79% |
| 2021-12-31 | NT$1.52 Billion | NT$111.66 Million | 0.073x | -8.23% |
| 2020-12-31 | NT$1.48 Billion | NT$118.27 Million | 0.080x | +55.11% |
| 2019-12-31 | NT$1.45 Billion | NT$74.52 Million | 0.051x | +43.51% |
| 2018-12-31 | NT$1.56 Billion | NT$56.03 Million | 0.036x | -36.63% |
| 2017-12-31 | NT$1.37 Billion | NT$77.56 Million | 0.057x | +59.70% |
| 2016-12-31 | NT$1.28 Billion | NT$45.34 Million | 0.035x | +1161.02% |
| 2015-12-31 | NT$1.50 Billion | NT$-5.01 Million | -0.003x | +91.40% |
| 2014-12-31 | NT$1.60 Billion | NT$-62.00 Million | -0.039x | -132.38% |
| 2013-12-31 | NT$837.28 Million | NT$100.37 Million | 0.120x | +538.11% |
| 2012-12-31 | NT$861.62 Million | NT$-23.58 Million | -0.027x | -161.99% |
| 2011-12-31 | NT$904.75 Million | NT$39.94 Million | 0.044x | -83.72% |
| 2010-12-31 | NT$737.87 Million | NT$200.03 Million | 0.271x | +58.78% |
| 2009-12-31 | NT$635.68 Million | NT$108.53 Million | 0.171x | +3.44% |
| 2008-12-31 | NT$609.60 Million | NT$100.62 Million | 0.165x | +99.72% |
| 2007-12-31 | NT$524.64 Million | NT$43.36 Million | 0.083x | +29.07% |
| 2006-12-31 | NT$461.75 Million | NT$29.56 Million | 0.064x | +94.99% |
| 2005-12-31 | NT$290.14 Million | NT$9.53 Million | 0.033x | -- |